Prognostic value of systemic immune-inflammatory index in hospitalized adolescent COVID-19 patients
Öz
Background: A new parameter called systemic immune-inflammatory index (SII), which is based on neutrophil-lymphocyte ratio (NLR) and platelet count, is used to examine the inflammatory and immune status of patients. The aim of this study was to evaluate the prognostic value of SII in adolescents diagnosed with COVID-19 and to compare SII with other biomarkers such as C-reactive protein (CRP)/albumin (Alb) ratio, D-dimer, lactate and NLR.
Methods: The medical records of hospitalized adolescent COVID-19 patients between April 1, 2020, and March 31, 2022, were retrospectively reviewed. A cut-off value for SII was obtained to examine the predictive value of SII for intensive care unit (ICU) admission as the primary outcome.
Results: A total of 177 patients with a mean age of 165.89 ± 26.60 months were included in the study. 97 (54.8%) of the patients were male. The most common presenting symptom was fever (n:102, 57.6%). Median (IQR) SII was 799 (951), lactate 1.9 (1.53), NLR 10.19 ± 6.77 and CRP/Alb ratio 1.55 (2.61). The cut-off value for SII in predicting ICU admission was ≥1111 (sensitivity, 78.6%; specificity, 75.2%; +likelihood ratio, (3.32); -likelihood ratio, 0.30; AUC:0.768) (p<0.001). While SII and CRP/Alb ratio were better than lactate in predicting ICU admission (p = 0.03 and p = 0.04, respectively), there was no statistical difference between SII and CRP/Alb ratio (p > 0.05).
Conclusion: The results of this study suggest that a high SII during hospitalization is associated with an increased likelihood of ICU admission in patients hospitalized with COVID-19. Although additional studies are needed to confirm and validate these findings, the evidence of this study supports SII is a valuable prognostic predictor of hospitilized patients with COVID-19.
Anahtar Kelimeler
Adolescent, COVID-19, prognosis, systemic immune-inflammatory index
Kaynakça
- 1. World Health Organization Coronavirus (COVID-19) Dashboard. https://covid19.who.int/ (Accessed August 1, 2024).
- 2. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(8):911-919.
- 3. Hoang A, Chorath K, Moreira M, Evans M, Burmeister-Morton F, Burmeister F, et al. COVID-19 in 7780 pediatric patients: a systematic review. EClinicalMedicine. 2020;24(100433).
- 4. Morand A., Fabre A, Minodier P, Boutin A, Vanel N, Bosdure E, et al. COVID-19 virus and children: What do we know? Arch Pediatr 2020;27(3):117-8.
- 5. Sperotto F, Friedman KG, Son MBF, VanderPluym CJ, Newburger JW, Dionne A. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021;180(2):307-322.
- 6. Çağlar HT, Pekcan S, Yılmaz Aİ, Ünal G, Metin Akcan Ö, Ünsaçar MZ, et al. Delta variant effect on the clinical course of adolescent COVID-19 patients. Pediatr Pulmonol. 2023;58(1):115-121.
- 7. Alifano M. Systemic immune-inflammation index and prognosis of advanced non-small cell lung cancer. Ann Transl Med. 2020;8(11):667.
- 8. Yang YL, Wu CH, Hsu PF, Chen SC, Huang SS, Chan WL, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230.
- 9. Trifan G, Testai FD. Systemic Immune-Inflammation (SII) index predicts poor outcome after spontaneous supratentorial intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2020;29(9):105057.
- 10. Seo M, Yamada T, Morita T, Frukawa Y, Tamaki S, Iwasaki Y, et al. Prognostic value of systemic immune-inflammation index in patients with chronic heart failure. Eur Heart J. 2018;39:ehy564.P589.